Literature DB >> 10841526

Glioblastoma multiforme: the terminator.

E C Holland1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10841526      PMCID： PMC33993          DOI： 10.1073/pnas.97.12.6242

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  15 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 2.  Molecular genetics and molecular biology advances in brain tumors.

Authors:  C D James; J J Olson
Journal:  Curr Opin Oncol       Date:  1996-05       Impact factor: 3.645

3.  The treatment of glioblastoma multiforme of the brain.

Authors:  R Jelsma; P C Bucy
Journal:  J Neurosurg       Date:  1967-11       Impact factor: 5.115

4.  Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma.

Authors:  A B Heimberger; L E Crotty; G E Archer; R E McLendon; A Friedman; G Dranoff; D D Bigner; J H Sampson
Journal:  J Neuroimmunol       Date:  2000-02-01       Impact factor: 3.478

5.  Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats.

Authors:  W E Carson; J G Jakowatz; R Yamamoto; T Fitzgerald; S Gupta; B Vayuvegula; J A Lucci; M T Beckman; S Dulkanchainun; G A Granger
Journal:  J Immunother (1991)       Date:  1991-04

6.  Intergeneric poliovirus recombinants for the treatment of malignant glioma.

Authors:  M Gromeier; S Lachmann; M R Rosenfeld; P H Gutin; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 7.  Gene transfer technologies for malignant gliomas.

Authors:  A Weyerbrock; E H Oldfield
Journal:  Curr Opin Oncol       Date:  1999-05       Impact factor: 3.645

8.  Successful treatment of a malignant rat glioma with cytotoxic T lymphocytes.

Authors:  F P Holladay; T Heitz; Y L Chen; M Chiga; G W Wood
Journal:  Neurosurgery       Date:  1992-09       Impact factor: 4.654

9.  Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.

Authors:  T Mineta; S D Rabkin; T Yazaki; W D Hunter; R L Martuza
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

10.  In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

Authors:  K W Culver; Z Ram; S Wallbridge; H Ishii; E H Oldfield; R M Blaese
Journal:  Science       Date:  1992-06-12       Impact factor: 47.728
View more
  242 in total

1.  mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.

Authors:  Federico Bolognani; Anne-Isabelle Gallani; Lena Sokol; David S Baskin; Nicole Meisner-Kober
Journal:  J Neurooncol       Date:  2011-09-21       Impact factor: 4.130

2.  Computational tools for the interactive exploration of proteomic and structural data.

Authors:  John H Morris; Elaine C Meng; Thomas E Ferrin
Journal:  Mol Cell Proteomics       Date:  2010-06-04       Impact factor: 5.911

3.  A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma.

Authors:  Dana A M Mustafa; Lennard J Dekker; Christoph Stingl; Andreas Kremer; Marcel Stoop; Peter A E Sillevis Smitt; Johan M Kros; Theo M Luider
Journal:  Mol Cell Proteomics       Date:  2012-01-25       Impact factor: 5.911

4.  Safe and Reproducible Preparation of Functional Dendritic Cells for Immunotherapy in Glioblastoma Patients.

Authors:  Sara Nava; Daniela Lisini; Simona Pogliani; Marta Dossena; Anna Bersano; Serena Pellegatta; Eugenio Parati; Gaetano Finocchiaro; Simona Frigerio
Journal:  Stem Cells Transl Med       Date:  2015-08-13       Impact factor: 6.940

5.  Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro.

Authors:  Isabele C Iser; Stefanie M Ceschini; Giovana R Onzi; Ana Paula S Bertoni; Guido Lenz; Márcia R Wink
Journal:  Mol Neurobiol       Date:  2015-12-19       Impact factor: 5.590

6.  Alkylation sensitivity screens reveal a conserved cross-species functionome.

Authors:  David Svilar; Madhu Dyavaiah; Ashley R Brown; Jiang-bo Tang; Jianfeng Li; Peter R McDonald; Tong Ying Shun; Andrea Braganza; Xiao-hong Wang; Salony Maniar; Claudette M St Croix; John S Lazo; Ian F Pollack; Thomas J Begley; Robert W Sobol
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

7.  Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.

Authors:  Marius Grzelinski; Florian Steinberg; Tobias Martens; Frank Czubayko; Katrin Lamszus; Achim Aigner
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

8.  Anticancer potential of aminomethylidene-diazinanes I. Synthesis of arylaminomethylidene of diazinetriones and its cytotoxic effects tested in glioblastoma cells.

Authors:  Nichole A Pianovich; Mathew Dean; Adam Lassak; Krzysztof Reiss; Branko S Jursic
Journal:  Bioorg Med Chem       Date:  2017-08-12       Impact factor: 3.641

Review 9.  Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.

Authors:  Shreyas S Rao; John J Lannutti; Mariano S Viapiano; Atom Sarkar; Jessica O Winter
Journal:  Tissue Eng Part B Rev       Date:  2013-10-30       Impact factor: 6.389

10.  Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas.

Authors:  Karl F Schmidt; Mateo Ziu; Nils Ole Schmidt; Pramil Vaghasia; Theresa G Cargioli; Sameer Doshi; Mitchell S Albert; Peter McL Black; Rona S Carroll; Yanping Sun
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.